Directory › CordenPharma

CordenPharma — Villars-Sur-Glane

Villars-Sur-Glane, Switzerland · CDMO

This is a record of what regulators published, not a rating.

Site facts

Company
CordenPharma
Name(s) in FDA data
Corden Pharma Fribourg SA
FEI number(s)
3009018997 (present in FDA Data Dashboard records for this name and city)
Location (as in FDA data)
Villars-Sur-Glane, Switzerland
Records matched
5 FDA inspections · 2 inspections with posted 483 citations
Most recent FDA inspection in dataset
26 Jun 2025 — VAI

Capabilities (from the company's website)

  • mRNA & lipid nanoparticles
    …ty Fact Sheet Drug Products Research & Development GMP Manufacturing Phase I-II Phase III LNP Formulation Regulatory Approval Commercialization Drug Products Drug Product Support Serv…

Taken from the part of the company's network/locations page that describes this site. Source: https://cordenpharma.com/how-we-deliver/facilities-network/, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.

Regulatory timeline

Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.

  1. 26 Jun 2025
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3009018997, inspection ID 1315750)

  2. 03 Feb 2023
    Form 483 observations 2 posted Form 483 citation(s)

    Citation summaries (2)
    • 21 CFR 211.180(e)(2): Items to cover on annual reviews
    • 21 CFR 211.192: Investigations of discrepancies, failures

    Source: FDA Data Dashboard – Citations (FEI 3009018997, inspection ID 1197386)

  3. 03 Feb 2023
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3009018997, inspection ID 1197386)

  4. 15 Jun 2018
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3009018997, inspection ID 1061458)

  5. 05 Jun 2014
    Form 483 observations 2 posted Form 483 citation(s)

    Citation summaries (2)
    • 21 CFR 211.194(a): Complete test data included in records
    • 21 CFR 211.22(d): Procedures not in writing, fully followed

    Source: FDA Data Dashboard – Citations (FEI 3009018997, inspection ID 883319)

  6. 05 Jun 2014
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3009018997, inspection ID 883319)

  7. 28 Jun 2012
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3009018997, inspection ID 802561)

This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.